Stapled peptide-based membrane fusion inhibitors of hepatitis C virus

被引：61
|
作者：
Cui, Hong-Kui [1 ]
Qing, Jie [1 ]
Guo, Ye [1 ]
Wang, Yu-Jia [1 ]
Cui, Li-Jia [2 ,3 ]
He, Tian-Hua [2 ,3 ]
Zhang, Linqi [2 ,3 ]
Liu, Lei [1 ]
机构：
[1] Tsinghua Univ, Dept Chem, Tsinghua Peking Ctr Life Sci,Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China
[2] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China
[3] Tsinghua Univ, Sch Med, Res Ctr Publ Hlth, Beijing 100084, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2013年 / 21卷 / 12期
基金：
中国国家自然科学基金;
关键词：
Hepatitis C virus; Stapled peptide; Protein-protein interaction; CELL-CULTURE SYSTEMS; B TYPE-I; OLEFIN METATHESIS; ALPHA-HELICES; BH3; HELIX; CD81; ENTRY; INFECTION; PROTEINS; RECEPTOR;
D O I：
10.1016/j.bmc.2013.02.011
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The strategy of peptide stapling was used to develop new molecules to inhibit the hepatitis C virus infection via disrupting the binding of HCV envelope glycoprotein E2 with human cell surface protein CD81. The peptide sequence was designed based on the large extra-cellular loop of CD81 with known importance in the HCV E2 binding interaction. Our results showed that the stapled peptides exhibited significantly higher alpha-helicity and proteolytic stability as compared to their linear peptide counterpart. The optimal compound was found to have an EC50 value of ca. 17-39 mu M against different HCV subtypes and represented a new HCV membrane fusion inhibitor. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3547 / 3554
页数：8
相关论文
共 50 条
  • [1] Perspectives: towards a peptide-based vaccine against hepatitis C virus
    Hunziker, IP
    Zurbriggen, R
    Glueck, R
    Engler, OB
    Reichen, J
    Dai, WJ
    Pichler, WJ
    Cerny, A
    MOLECULAR IMMUNOLOGY, 2001, 38 (06) : 475 - 484
  • [2] Conjugation of spermine enhances cellular uptake of the stapled peptide-based inhibitors of p53-Mdm2 interaction
    Muppidi, Avinash
    Li, Xiaolong
    Chen, Jiandong
    Lin, Qing
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (24) : 7412 - 7415
  • [3] A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
    Banda, Dominic H.
    Perin, Paula M.
    Brown, Richard J. P.
    Todt, Daniel
    Solodenko, Wladimir
    Hoffmeyer, Patrick
    Sahu, Kamlesh Kumar
    Houghton, Michael
    Meuleman, Philip
    Mueller, Rolf
    Kirschning, Andreas
    Pietschmann, Thomas
    JOURNAL OF HEPATOLOGY, 2019, 70 (06) : 1082 - 1092
  • [4] Stapled Peptides-A Useful Improvement for Peptide-Based Drugs
    Moiola, Mattia
    Memeo, Misal G.
    Quadrelli, Paolo
    MOLECULES, 2019, 24 (20):
  • [5] Emerging hepatitis C virus inhibitors
    Varshney, Jonish
    Sharma, Anjana
    Sharma, Pramod Kumar
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (03) : 1043 - 1048
  • [6] Design and synthesis of membrane fusion inhibitors against the feline immunodeficiency virus
    Oishi, Shinya
    Kodera, Yasuyo
    Nishikawa, Hiroki
    Kamitani, Hirotaka
    Watabe, Tsuyoshi
    Ohno, Hiroaki
    Tochikura, Tadafumi
    Shimane, Kazuki
    Kodama, Eiichi
    Matsuoka, Masao
    Mizukoshi, Fuminori
    Tsujimoto, Hajime
    Fujii, Nobutaka
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (14) : 4916 - 4920
  • [7] Improved Dendritic Cell-Based Immunization Against Hepatitis C Virus Using Peptide Inhibitors of Interleukin 10
    Diaz-Valdes, Nancy
    Manterolal, Lorea
    Belsue, Virginia
    Riezu-Boj, Jose I.
    Larrea, Esther
    Echeverria, Itziar
    Llopiz, Diana
    Lopez-Sagaseta, Jacinto
    Lerat, Herve
    Pawlotsky, Jean-Michel
    Prieto, Jesus
    Lasarte, Juan J.
    Borras-Cuesta, Francisco
    Sarobe, Pablo
    HEPATOLOGY, 2011, 53 (01) : 23 - 31
  • [8] Peptide-Based Inhibitors of the HIV Envelope Protein and Other Class I Viral Fusion Proteins
    Steffen, Imke
    Poehlmann, Stefan
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (09) : 1143 - 1158
  • [9] Hepatitis C virus resistance to protease inhibitors
    Halfon, Philippe
    Locarnini, Stephen
    JOURNAL OF HEPATOLOGY, 2011, 55 (01) : 192 - 206
  • [10] Peptide-based inhibitors of protein-protein interactions
    Wojcik, Paulina
    Berlicki, Lukasz
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (03) : 707 - 713
12345